Eduardo Emrich Soares

President & CEO

Eduardo is the CEO and President of Biominas Brasil since 2003. In this period, Biominas have has identified and analyzed more than 600 technologies from Brazilian research institutions and supplied consulting services to more than 100 local and foreign companies. Eduardo was co-founder of Alvos Biotec, a virtual product development company, sold to Ourofino Animal Health in 2011. Eduardo is also a board member at several life sciences companies, such as Prodimol (sold to Inverness Group), Linhagen and Biocancer/Trymed.

Eduardo has a degree in Biological Sciences from the Federal University of Minas Gerais as well as completing the Executive MBA Course from Fundação Getúlio Vargas and Financial Management Course from Fundação Dom Cabral.